HRT & Longevity Clinic Valuation
Hormone optimization sits inside a longevity market that private equity is funding aggressively, and recurring, cash-pay patient relationships make it one of the more durable wellness models. The first question to answer is what your clinic is worth today, and how much a membership model would add to that number.
Free valuation calculator What moves your number Jump to FAQs
No upfront fee. No obligation. Success-based, confidentiality-first advisory.
Why is HRT clinic valuation different?
HRT valuation is different because the revenue is mostly cash-pay and the best practices turn it into recurring, multi-year relationships. A clinic where patients renew on a membership or subscription is valued far more richly than one that starts every month at zero, because the buyer can forecast the cash flow.
As of June 2026, single-location clinics generally trade around 3.0x to 6.0x SDE or 4.0x to 7.0x EBITDA, multi-location or platform-quality practices 7.0x to 10.0x or higher, and VC- or PE-backed longevity platforms 10.0x to 15.0x or higher. These are ranges, not promises. Where you land depends on recurring revenue, customer lifetime value, service breadth, and how much rides on the founder.
Recurring revenue
Membership and subscription models convert visits into predictable income, the single biggest driver of a premium multiple.
Customer lifetime value
HRT patients often stay on three- to five-year plans, so a loyal panel represents years of forecastable revenue buyers will pay for.
Scalable delivery
Telehealth reach and NP/PA-delivered care reduce founder dependence and let a buyer grow the model without new real estate.
What do buyers look for in an HRT acquisition?
Buyers look for durable, recurring cash-pay revenue delivered by a team rather than a single founder. The most active acquirers are private-equity-backed longevity platforms, health-tech companies adding clinical services, and strategic wellness operators.
- Recurring membership or subscription revenue — a large share of income that renews on a known schedule.
- High customer lifetime value — long-term patients on multi-year treatment plans.
- A diversified service mix — HRT alongside weight loss, lab testing, and wellness that deepen each relationship.
- Scalable, compliant telehealth — multi-state licensing handled and protocols documented.
- Provider depth beyond the founder — NPs and PAs delivering care under standardized protocols.
- Clean financials — adjusted EBITDA with defensible add-backs and organized patient and revenue data.
What drives an HRT clinic’s valuation multiple?
The multiple a buyer applies reflects how predictable and transferable your revenue is. These are the levers that move it most, and shifting from transactional visits to a membership model is usually the highest-impact one.
| Value driver | Effect on multiple | Why buyers care |
|---|---|---|
| Recurring membership / subscription revenue | Raises | Predictable, forecastable cash flow |
| High customer lifetime value (3–5 yr plans) | Raises | Years of revenue per patient acquired |
| Diversified service mix + scalable telehealth | Raises | Stickier relationships and lower founder reliance |
| Founder-doctor dependence | Lowers | Revenue and brand may leave with the founder |
| Purely transactional (non-recurring) revenue | Lowers | Income resets each month and is harder to forecast |
Directional effect on HRT and longevity clinic multiples, as of mid-2026. Sources: VMG Health and Future Market Insights longevity reporting, 2025–2026. Most of these levers can be improved in the 12 months before a sale.
How does the sale process work?
A confidential process typically runs 6 to 9 months from valuation to close. Starting 12 months ahead gives you time to build recurring revenue, broaden services, and reduce founder dependence before going to market.
Baseline value + prep plan
We rebuild adjusted EBITDA, measure recurring revenue and lifetime value, and target the levers that lift your multiple.
Confidential marketing
We approach qualified longevity platforms and strategic buyers behind NDAs, protecting your patients and brand.
Diligence + close
We manage clinical, regulatory, and financial diligence, negotiate terms, and guide the transition so value holds.
What should HRT owners know about the market?
Demand for hormone optimization and preventive, longevity-focused care continues to grow, and private capital is building platforms to consolidate a fragmented field. That makes 2026 a strong market for prepared sellers, where a recurring-revenue model and provider depth separate premium clinics from owner-dependent ones.
EBITDA range, from single clinics to backed platforms
annual growth in the HRT market ($23.6B toward $38B by 2033)
typical patient relationship, the core lifetime-value driver
Sources: Fortune Business Insights HRT market; VMG Health private equity in HRT; Future Market Insights longevity clinic infrastructure, 2025–2026.
See where your HRT clinic stands
Start with a confidential estimate, then test the number against live buyer demand. A valuation is a planning tool. It commits you to nothing.
No upfront fee. No obligation.
Resources to go deeper
HRT clinic valuation & selling FAQs
How is an HRT or longevity clinic valued?
An HRT or longevity clinic is valued by normalizing earnings into adjusted EBITDA (or seller’s discretionary earnings for smaller owner-run clinics), applying a market multiple for your size and model, and adjusting for recurring revenue, customer lifetime value, service breadth, and founder dependence.
What multiple do hormone therapy practices sell for?
As of June 2026, single-location clinics generally sell for 3.0x to 6.0x SDE or 4.0x to 7.0x EBITDA, multi-location or platform-quality practices 7.0x to 10.0x or higher, and VC- or PE-backed longevity platforms 10.0x to 15.0x or higher.
How much does recurring or membership revenue increase value?
A great deal. Buyers pay a higher multiple for income they can forecast, so converting transactional visits into memberships or subscriptions is usually the single most effective way to raise an HRT clinic’s valuation.
Why are longevity platforms buying HRT clinics?
Longevity platforms are consolidating a fragmented, fast-growing, cash-pay field with loyal patients and high lifetime value. HRT clinics with recurring revenue and provider depth are attractive add-ons that scale within a larger preventive-health model.
Does a telehealth model raise valuation?
Generally yes, when it is compliant. Telehealth extends reach without new real estate and supports NP/PA-delivered care, which reduces founder dependence and makes the model easier for a buyer to scale, both of which support a higher multiple.
Will a valuation obligate me to sell?
No. A valuation is confidential and carries no obligation. It is a planning tool that tells you what your clinic is worth today and what would make it worth more, so any future decision is yours to make on your own timeline.
Find out what your HRT clinic is worth
Vallexa Advisors is a healthcare-only M&A firm. We help owners understand value, prepare intelligently, and run a confidential sale process that attracts qualified buyers.
No upfront fee. No obligation. 100% success-based.
Educational only. Not legal, financial, or tax advice. HRT and longevity M&A outcomes depend on specific facts, revenue model, state regulation, market conditions, and regulatory context. Speak with qualified counsel before acting on anything on this page.
- Home Health Agency Valuation & Sale Process (Owner Guide) | Vallexa Advisors
- Hospice Valuation & Selling Guide (for Owners)
- Home Care Business Valuation & Selling Guide (Private Duty / Non-Medical)
- Behavioral Health Practice Valuation & Sale Process
- Med Spa Valuation & Sale Process
- Infusion Center Valuation & Sale Process
- RCM / Medical Billing Company Valuation
- Dental Practice Valuation & DSO Sale
- Clinical Research Site Valuation & Sale Process